Upcoming events

Switch to Calendar View

• ASENT 2025 Clinical Trials Course

  • Start
    March 10, 2025
  • End
    March 11, 2025
  • Location
    Hyatt Regency Bethesda, Bethesda MD

  Training in Neurotherapeutic Clinical Trials: Development and Implementation Course

  APPLICATION DEADLINE EXTENDED: NOVEMBER 19, 2024

  APPLY TODAY

  DOWNLOAD THE BROCHURE

  About the Course

  • Format: In Person 
  • Application: Free 
  • Tuition: $450 for Accepted Applicants 
  • Requirements: Completed Application 
  • Credentials Provided: Certificate of Completion 
  • Included: Course materials, Discounted Registration for ASENT Annual Meeting, Discounted fee to Submit Abstract to ASENT. 
  • Not Included: Travel and Hotel is not included for all participants

  
  

  ASENT is pleased to offer a 2-day course March 10-11, 2025 at the Hyatt Regency Bethesda, in Bethesda, MD to introduce researchers and clinicians to the principles of neurotherapeutic clinical trial development and implementation. The course will be especially relevant if you are interested in conducting neurotherapeutic clinical trials.

  The course covers the principles of clinical trials from pre-clinical programs to Phase III design and implementation, including necessary regulatory conversations and IND enabling studies, IRB oversight and adverse event tracking and reporting. The course considers clinical trials in the neurotherapeutic space for both drugs and devices. The course will also address the unique challenges inherent in developing treatments for nervous system disorders. 

  The course will feature a mix of:

  • Didactic sessions that go in depth into a wide range of topics

  • Interactive workshops where participants will work in teams on projects such as drafting protocols and addressing adverse events 

  • Panel discussions with lively Q&A 

  • Discounted access to the ASENT Annual Meeting

  APPLY TODAY

  DOWNLOAD THE BROCHURE

  
  

  Participants who attend the course will have ongoing access to senior faculty in attendance in a mentoring capacity. We anticipate that most applicants will have some familiarity with clinical research however, any clinical investigator who would benefit from the course is invited to apply. Those in industry and in private practice are also welcome to apply. The course will be offered annually and participants have discounted access to the ASENT Annual Meeting.

  You will be asked to provide:
  

  • Name
  • Contact Information
  • CV
  • A one page letter of interest

  We are excited to have the opportunity to offer this course, which we believe will help to advance the availability of new drugs for patients with neurological conditions. If your work would benefit from an understanding of neurologic clinical trials you are encouraged to apply.

  APPLY TODAY

  DOWNLOAD THE BROCHURE
  

  
  

  Show details
• ASENT 2025 Annual Meeting

  • Start
    March 12, 2025
  •  
    8:00 AM
  • End
    March 14, 2025
  •  
    1:00 PM
  • Location
    Hyatt Regency Bethesda, Bethesda, MD

  Register

  ABOUT ASENT 2025 Annual Meeting

  The ASENT 2025 Annual Meeting, which will take place March 12 - 14, 2025 at the Hyatt Regency Bethesda in Bethesda, MD, is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market.

  The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

  WHO ATTENDS

  Physician-Scientists | Neurologists | Neuroscientists | Trainees | Drug and Device Companies | CROs | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

  
  

  Show details